Brief: Bio-Rad Q1 Sales USD 592.1 Million
30/04/2026 21:15
Apr 30 (Reuters) - Bio-Rad Q1 EPS USD -19.55. Q1 gross margin 52.3% Q1 net income USD -527.1 million outlook FY adjusted revenue growth -3%
Recent news on Bio-Rad Laboratories
See all newsBio-Rad Laboratories, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Bio-Rad Laboratories On July 31, Initiated Restructuring Plan - SEC Filing
Bio-Rad Q2 revenue beats analyst estimates on clinical diagnostics growth
Brief: Bio-Rad Q2 Net Income USD 371.4 Million
Activist investors make bigger push for campaigns in H1, seek more M&A